NDC Code(s) : 51079-195-01, 51079-195-03, 51079-196-01, 51079-196-03
Packager : Mylan Institutional Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Fenofibric Acidfenofibric acid CAPSULE, DELAYED RELEASE PELLETS | ||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
Fenofibric Acidfenofibric acid CAPSULE, DELAYED RELEASE PELLETS | ||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL – 45 mg
NDC 51079-195-03
Fenofibric Acid
Delayed-release
Capsules
45 mg*
30 Capsules (3 x 10)
*Each capsule contains choline
fenofibrate equivalent to 45 mg
of fenofibric acid.
Usual Dosage: See accompanying
prescribing information and Medication
Guide.
Swallow whole. Do not open,
crush, dissolve or chew capsules.
Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room Temperature.]
Protect from moisture.
Manufactured by:
Mylan Pharmaceuticals Inc.
Morgantown, WV 26505 U.S.A.
Rx only
S-12011
Packaged and Distributed by:
Mylan Institutional Inc.
Rockford, IL 61103 U.S.A.
This unit dose package is not child resistant.
For institutional use only.
Keep this and all drugs out of the reach of children.
This container provides light-resistance.
See window for lot number and expiration date.


PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL – 135 mg
NDC 51079-196-03
Fenofibric Acid
Delayed-release
Capsules
135 mg*
30 Capsules (3 x 10)
*Each capsule contains choline
fenofibrate equivalent to 135 mg
of fenofibric acid.
Usual Dosage: See accompanying
prescribing information and Medication
Guide.
Swallow whole. Do not open,
crush, dissolve or chew capsules.
Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room Temperature.]
Protect from moisture.
Manufactured by:
Mylan Pharmaceuticals Inc.
Morgantown, WV 26505 U.S.A.
Rx only
S-12012
Packaged and Distributed by:
Mylan Institutional Inc.
Rockford, IL 61103 U.S.A.
This unit dose package is not child resistant.
For institutional use only.
Keep this and all drugs out of the reach of children.
This container provides light-resistance.
See window for lot number and expiration date.

